Literature DB >> 24582100

Osteoporosis-associated fracture and diabetes.

Salila Kurra1, Dorothy A Fink2, Ethel S Siris3.   

Abstract

Osteoporosis and diabetes mellitus are chronic diseases with significant associated morbidity and mortality. Recent evidence suggests that both type 1 and type 2 diabetes are associated with an increased fracture risk. Fracture as a complication of diabetes must be considered when evaluating and treating patients with diabetes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Diabetes; Diabetes complications; Fracture; Osteoporosis; Skeletal disorder

Mesh：

Year:  2013        PMID： 24582100     DOI： 10.1016/j.ecl.2013.09.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  31 in total

1.  COPD as an independent risk factor for osteoporosis and fractures.

Authors:  M G Adas-Okuma; S S Maeda; M R Gazzotti; C M Roco; C O Pradella; O A Nascimento; E F Porto; J G H Vieira; J R Jardim; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2019-12-06       Impact factor: 4.507

2.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

3.  Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover.

Authors:  Georgia Colleluori; Lina Aguirre; Richard Dorin; David Robbins; Dean Blevins; Yoann Barnouin; Rui Chen; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Bone       Date:  2017-03-16       Impact factor: 4.398

4.  Association between lipid biomarkers and osteoporosis: a cross-sectional study.

Authors:  Bo Kan; Qianqian Zhao; Lijuan Wang; Shanshan Xue; Hanqing Cai; Shuman Yang
Journal:  BMC Musculoskelet Disord       Date:  2021-09-06       Impact factor: 2.362

5.  The m6A demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.

Authors:  Liu-Shan Chen; Meng Zhang; Peng Chen; Xiao-Feng Xiong; Pei-Qing Liu; Hai-Bin Wang; Jun-Jian Wang; Juan Shen
Journal:  Acta Pharmacol Sin       Date:  2021-08-30       Impact factor: 7.169

6.  Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.

Authors:  Georgia Colleluori; Lina Aguirre; Nicola Napoli; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 6.134

Review 7.  Mechanisms involved in altered bone metabolism in diabetes: a narrative review.

Authors:  Maryam Ghodsi; Bagher Larijani; Abbass Ali Keshtkar; Ensieh Nasli-Esfahani; Sudabeh Alatab; Mohammad Reza Mohajeri-Tehrani
Journal:  J Diabetes Metab Disord       Date:  2016-11-15

8.  Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years.

Authors:  Minyan Liu; Yanhui Lu; Xiaoling Cheng; Lichao Ma; Xinyu Miao; Nan Li; Boruo Sun; Shuangtong Yan; Jian Li; Chunling Li
Journal:  Clin Interv Aging       Date:  2019-02-25       Impact factor: 4.458

9.  High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7.

Authors:  Jinsan Yang; Cao Ma; Maoshu Zhang
Journal:  Mol Med Rep       Date:  2019-10-31       Impact factor: 2.952

10.  Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.

Authors:  Tianshu Shi; Ke Lu; Siyu Shen; Qiaoli Tang; Kaijia Zhang; Xiaobo Zhu; Yong Shi; Xianglin Liu; Huajian Teng; Chaojun Li; Bin Xue; Qing Jiang
Journal:  Lipids Health Dis       Date:  2017-10-13       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.